BVOIX | VVIAX | BVOIX / VVIAX | |
Total Expense Ratio | 0.70 | 0.05 | 1,400% |
Annual Report Gross Expense Ratio | 0.72 | 0.05 | 1,440% |
Fund Existence | 3 years | 25 years | - |
Gain YTD | -1.123 | 2.436 | -46% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 3000 | 3,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 97.1M | 189B | 0% |
Annual Yield % from dividends | 1.29 | 2.28 | 57% |
Returns for 1 year | -1.53 | 8.01 | -19% |
Returns for 3 years | 31.39 | 32.19 | 97% |
Returns for 5 years | N/A | 72.56 | - |
Returns for 10 years | N/A | 103.54 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CVSB | 50.67 | -0.06 | -0.12% |
Calvert Ultra-Short Investment Grade ETF | |||
FMED | 23.74 | -0.18 | -0.75% |
Fidelity Disruptive Medicine ETF | |||
AOM | 45.09 | -0.35 | -0.77% |
iShares Core 40/60 Moderate Allc ETF | |||
RSPU | 70.86 | -0.62 | -0.87% |
Invesco S&P 500® Equal Weight Utilts ETF | |||
VYM | 130.54 | -1.31 | -0.99% |
Vanguard High Dividend Yield ETF |